Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun-Shu Lin

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Radiation Oncology (London, England)|January 15, 2021
Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case seriesYing-Fu Wang, Yang-Hong Dai, Chun-Shu Lin, et al.
Tumori|January 7, 2017
Stereotactic ablative radiotherapy for patients with unresectable or medically inoperable cholangiocarcinomaMing-Yueh Liu, Cheng-Hsiang Lo, Chun-Shu Lin, et al.
Plos One|April 7, 2017
Risk of second primary malignancies among patients with prostate cancer: A population-based cohort studyChao-Yueh Fan, Wen-Yen Huang, Chun-Shu Lin, et al.
Journal of Hepatocellular Carcinoma|November 12, 2021
Dynamic Changes in Neutrophil-to-Lymphocyte Ratio are Associated with Survival and Liver Toxicity Following Stereotactic Body Radiotherapy for Hepatocellular CarcinomaChih-Weim Hsiang, Wen-Yen Huang, Jen-Fu Yang, et al.
Scientific Reports|November 9, 2022
Significant muscle loss after stereotactic body radiotherapy predicts worse survival in patients with hepatocellular carcinomaJen-Fu Yang, Wen-Yen Huang, Cheng-Hsiang Lo, et al.
Journal of Dental Sciences|February 2, 2024
MiR-34a functions as a tumor suppressor in oral cancer through the inhibition of the Axl/Akt/GSK-3β pathwayYu-Fu Su, Chun-Shu Lin, Po-Chien Shen, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2017
Comparison Between Child-Turcotte-Pugh and Albumin-Bilirubin Scores in Assessing the Prognosis of Hepatocellular Carcinoma After Stereotactic Ablative Radiation TherapyCheng-Hsiang Lo, Ming-Yueh Liu, Meei-Shyuan Lee, et al.
Plos One|March 4, 2014
Features on MDCT that predict surgery in patients with adhesive-related small bowel obstructionWei-Chou Chang, Kai-Hsiung Ko, Chun-Shu Lin, et al.
Medicine|March 18, 2016
Long-Term Breast Cancer Patient Outcomes After Adjuvant Radiotherapy Using Intensity-Modulated Radiotherapy or Conventional Tangential RadiotherapyJen-Fu Yang, Meei-Shyuan Lee, Chun-Shu Lin, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|January 23, 2019
Ovatodiolide suppresses nasopharyngeal cancer by targeting stem cell-like population, inducing apoptosis, inhibiting EMT and dysregulating JAK/STAT signaling pathwayShao-Cheng Liu, Chih-Ming Huang, Oluwaseun Adebayo Bamodu, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Radiation Oncology (London, England)|January 15, 2021
Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case seriesYing-Fu Wang, Yang-Hong Dai, Chun-Shu Lin, et al.
Tumori|January 7, 2017
Stereotactic ablative radiotherapy for patients with unresectable or medically inoperable cholangiocarcinomaMing-Yueh Liu, Cheng-Hsiang Lo, Chun-Shu Lin, et al.
Plos One|April 7, 2017
Risk of second primary malignancies among patients with prostate cancer: A population-based cohort studyChao-Yueh Fan, Wen-Yen Huang, Chun-Shu Lin, et al.
Journal of Hepatocellular Carcinoma|November 12, 2021
Dynamic Changes in Neutrophil-to-Lymphocyte Ratio are Associated with Survival and Liver Toxicity Following Stereotactic Body Radiotherapy for Hepatocellular CarcinomaChih-Weim Hsiang, Wen-Yen Huang, Jen-Fu Yang, et al.
Scientific Reports|November 9, 2022
Significant muscle loss after stereotactic body radiotherapy predicts worse survival in patients with hepatocellular carcinomaJen-Fu Yang, Wen-Yen Huang, Cheng-Hsiang Lo, et al.
Journal of Dental Sciences|February 2, 2024
MiR-34a functions as a tumor suppressor in oral cancer through the inhibition of the Axl/Akt/GSK-3β pathwayYu-Fu Su, Chun-Shu Lin, Po-Chien Shen, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2017
Comparison Between Child-Turcotte-Pugh and Albumin-Bilirubin Scores in Assessing the Prognosis of Hepatocellular Carcinoma After Stereotactic Ablative Radiation TherapyCheng-Hsiang Lo, Ming-Yueh Liu, Meei-Shyuan Lee, et al.
Plos One|March 4, 2014
Features on MDCT that predict surgery in patients with adhesive-related small bowel obstructionWei-Chou Chang, Kai-Hsiung Ko, Chun-Shu Lin, et al.
Medicine|March 18, 2016
Long-Term Breast Cancer Patient Outcomes After Adjuvant Radiotherapy Using Intensity-Modulated Radiotherapy or Conventional Tangential RadiotherapyJen-Fu Yang, Meei-Shyuan Lee, Chun-Shu Lin, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|January 23, 2019
Ovatodiolide suppresses nasopharyngeal cancer by targeting stem cell-like population, inducing apoptosis, inhibiting EMT and dysregulating JAK/STAT signaling pathwayShao-Cheng Liu, Chih-Ming Huang, Oluwaseun Adebayo Bamodu, et al.
Pageof 9